Profile: Bio-Techne Corp (TECH.OQ)
16 Aug 2019
Bio-Techne Corporation, incorporated on July 17, 1981, develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics.
Protein Sciences segment
The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis.
Diagnostics and Genomics segment
The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market. The Diagnostics and Genomics segment also develops and commercializes in situ hybridization products and exosome-based diagnostics for various pathologies, including prostate cancer.
614 McKinley Pl NE
MINNEAPOLIS MN 55413-2610